Clinical Trial Update: Phase II Study of Gamma Knife Radiosurgery and Temozolomide for Brain Metastases [Phase 2]

View source ↗

Summary

Phase II study evaluating gamma knife radiosurgery with temozolomide for brain metastases has completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Cancer

Drugs mentioned

• Gamma Knife radiosurgery
• Temozolomide (Temozolomide)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Cancer, Brain Metastases | Phase 2 | Status: COMPLETED | Results posted: 2015-09-17